Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 4/11/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Michael Reedijk?

Michael Reedijk

Principal Investigator

University Health Network

HQ Phone:  (416) 340-4800

Email: m***@***.ca

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

University Health Network

190 Elizabeth Street

Toronto, Ontario,M5G 2C4

Canada

Company Description

University Health Network consists of Toronto General and Toronto Western Hospitals, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, and The Michener Institute for Education at UHN. The scope of research and complexity of cases at Univer... more

Find other employees at this company (14,130)

Background Information

Employment History

Surgical Oncologist

Princess Margaret Hospital


Head of Research, Department of Surgical Oncology

Mount Sinai Hospital


Affiliations

Royal College of Physicians

Fellow


Education

PhD


PhD

University of Toronto , ON.


Web References(27 Total References)


Principal Investigators - The Campbell Family Institute for Cancer Research

www.campbellfamilyinstitute.ca [cached]

Dr. Michael Reedijk
Surgeon-Scientist Dr. Reedijk is a surgical oncologist with both clinical and research interests in breast cancer. He completed his doctoral and medical studies at the University of Toronto. His research examines the role of Notch family signaling molecules in human breast cancer. Dr. Reedijk's findings indicate that the Notch gene is abnormally expressed in a significant proportion of breast cancers and that this correlates with poor outcome in patients. Current efforts in his laboratory are focused on determining whether Notch signaling genes can serve as therapeutic targets in breast cancer. Dr. Reedijk has received several awards for his research including the James Ewing Oncology Fellowship Award for Basic Research and the Society of University Surgeons Junior Faculty Grant Award.


Breast Cancer - The Campbell Family Institute for Cancer Research

www.campbellfamilyinstitute.ca [cached]

Dr. Michael Reedijk
Surgeon-Scientist Dr. Reedijk is a surgical oncologist with both clinical and research interests in breast cancer. He completed his doctoral and medical studies at the University of Toronto. His research examines the role of Notch family signaling molecules in human breast cancer. Dr. Reedijk's findings indicate that the Notch gene is abnormally expressed in a significant proportion of breast cancers and that this correlates with poor outcome in patients. Current efforts in his laboratory are focused on determining whether Notch signaling genes can serve as therapeutic targets in breast cancer. Dr. Reedijk has received several awards for his research including the James Ewing Oncology Fellowship Award for Basic Research and the Society of University Surgeons Junior Faculty Grant Award.


Reedijk, M.

generalsurgery.utoronto.ca [cached]

Michael Reedijk, PhD, MD, FRCSC
Division of General Surgery Dr. Michael Reedijk, a graduate of the Department of Microbiology and Immunology at McGill University, completed his Doctoral studies in signal transduction in the Department of Medical Genetics at the University of Toronto in 1993. Overlapping with his Ph.D. studies, Dr. Reedijk completed undergraduate training in Medicine (U of T), graduating in 1995. Dr. Reedijk began specialty training at the University of Toronto in General Surgery in 1996, and became a Fellow of the Royal College of Physicians and Surgeons of Canada in 2001. After completing combined clinical (Surgical Oncology) and post-doctoral research (Hospital for Sick Children - Division of Blood and Cancer) fellowships, Dr. Reedijk began his Surgical Oncology Staff Appointments at Mount Sinai Hospital and University Health Network in 2003. He is currently an Assistant Professor in the Department of Surgery at the University of Toronto. His clinical practice is devoted to the surgical treatment of melanoma and malignancies of the breast. In 2007 Dr. Reedijk was cross-appointed as an Assistant Professor in the Department of Medical Biophysics at the University of Toronto. His research lab is within The Campbell Family Institute for Breast Cancer Research/Ontario Cancer Institute at the Princess Margaret Hospital where his focus is on Notch Signaling in Breast Cancer. Dr. Reedijk was appointed as the Head of Research, Department of Surgical Oncology at the University Health Network and Mount Sinai Hospital in 2006.


breastcancer.campbellfamilyinstitute.ca

Dr. Michael Reedijk
Surgeon-Scientist


breastcancer.campbellfamilyinstitute.ca

Dr. Michael Reedijk
Surgeon-Scientist Dr. Reedijk is a surgical oncologist with both clinical and research interests in breast cancer. He completed his doctoral and medical studies at the University of Toronto. His research examines the role of Notch family signaling molecules in human breast cancer. Dr. Reedijk's findings indicate that the Notch gene is abnormally expressed in a significant proportion of breast cancers and that this correlates with poor outcome in patients. Current efforts in his laboratory are focused on determining whether Notch signaling genes can serve as therapeutic targets in breast cancer. Dr. Reedijk has received several awards for his research including the James Ewing Oncology Fellowship Award for Basic Research and the Society of University Surgeons Junior Faculty Grant Award.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory